Renibus Therapeutics
Renibus Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
About Renibus Therapeutics
Renibus Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Renibus Therapeutics is a clinical-stage biopharmaceutical company developing therapies to prevent disease progression and protect against organ damage in cardiovascular, renal, and metabolic diseases, with lead assets including the Phase 3 candidate Veverimer and the cardiac surgery asset RBT-1.
Explore Renibus Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.